Literature DB >> 1394175

Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence.

P Hartge1, S S Devesa.   

Abstract

The incidence of non-Hodgkin's lymphoma among white men in the United States was measured as 6.9/100,000 person-years in 1947-1950 and as 17.4 in 1984-1988. We have estimated how much the known and suspected diagnostic and risk factors might have contributed to this apparent increase of 152%. Firm conclusions cannot be drawn without more data on risk and changes in prevalence, but a reasonable range of impacts can be constructed. After accounting for the likely effects of misdiagnosis of Hodgkin's disease as non-Hodgkin's lymphoma, of the acceptance of new entities of non-Hodgkin's lymphoma, of familial factors, of human immunodeficiency virus and other immunosuppressive conditions or drugs, and of occupation, we estimate that the percentage increase in incidence was still 80% among all males and 42% among those aged 0-64. An agent carrying a relative risk of 2.0 rising in prevalence from 0 to 42% would account for the latter rise. Diet, hair dyes, and general environmental exposures to pesticides may be contributing, but currently estimated risks and changes in exposure levels do not appear large enough to account for the residual rise. Among men aged 75-84, some of the residual rise of 109% probably is diagnostic, but only further research will clarify the issue.

Entities:  

Mesh:

Year:  1992        PMID: 1394175

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Leukemia, lymphoma, and multiple myeloma following selected medical conditions.

Authors:  M M Doody; M S Linet; A G Glass; G D Friedman; L M Pottern; J D Boice; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

2.  Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma.

Authors:  Loretta J Nastoupil; Rajni Sinha; Christopher R Flowers
Journal:  Eur Oncol Haematol       Date:  2012-05

3.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

4.  Occupational exposures and non-Hodgkin lymphoma: where do we stand?

Authors:  A Blair
Journal:  Occup Environ Med       Date:  2006-01       Impact factor: 4.402

5.  Occupation and malignant lymphoma: a population based case control study in Germany.

Authors:  B Mester; A Nieters; E Deeg; G Elsner; N Becker; A Seidler
Journal:  Occup Environ Med       Date:  2006-01       Impact factor: 4.402

Review 6.  Diffuse large B-cell lymphoma.

Authors:  Jonathan W Friedberg; Richard I Fisher
Journal:  Hematol Oncol Clin North Am       Date:  2008-10       Impact factor: 3.722

7.  Solvent exposure and non-Hodgkin lymphoma: no risk in a population-based study in the San Francisco Bay Area.

Authors:  Gregory J Tranah; Elizabeth A Holly; Paige M Bracci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

8.  Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men.

Authors:  Kimberly A Bertrand; Donna Spiegelman; Jon C Aster; Larisa M Altshul; Susan A Korrick; Scott J Rodig; Shumin M Zhang; Tobias Kurth; Francine Laden
Journal:  Epidemiology       Date:  2010-03       Impact factor: 4.822

Review 9.  Next-generation prognostic assessment for diffuse large B-cell lymphoma.

Authors:  Ashley D Staton; Jean L Koff; Qiushi Chen; Turgay Ayer; Christopher R Flowers
Journal:  Future Oncol       Date:  2015-08-20       Impact factor: 3.404

10.  Polycyclic aromatic hydrocarbons: determinants of residential carpet dust levels and risk of non-Hodgkin lymphoma.

Authors:  Curt T DellaValle; Nicole C Deziel; Rena R Jones; Joanne S Colt; Anneclaire J De Roos; James R Cerhan; Wendy Cozen; Richard K Severson; Abigail R Flory; Lindsay M Morton; Mary H Ward
Journal:  Cancer Causes Control       Date:  2015-11-16       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.